Nicotinic acetylcholine receptor partial agonist

This page covers all Nicotinic acetylcholine receptor partial agonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Nicotinic acetylcholine receptors.

Targets

Nicotinic acetylcholine receptors

Marketed (1)

• Cytisinicline and exercise · Maimónides Biomedical Research Institute of Córdoba · Addiction/Smoking Cessation
  Cytisinicline is a partial agonist of nicotinic acetylcholine receptors that reduces nicotine craving and withdrawal symptoms, combined with exercise to enhance smoking cessation outcomes.

Patent intelligence

• nicotinic acetylcholine receptor partial agonist patent landscape — aggregated cliff calendar, attackable patents, originator estates